A detailed history of Callan Family Office, LLC transactions in Danaher Corp stock. As of the latest transaction made, Callan Family Office, LLC holds 1,823 shares of DHR stock, worth $420,657. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,823
Previous 1,605 13.58%
Holding current value
$420,657
Previous $401 Million 26.39%
% of portfolio
0.09%
Previous 0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$239.25 - $280.76 $52,156 - $61,205
218 Added 13.58%
1,823 $507 Million
Q2 2024

Jul 25, 2024

BUY
$235.51 - $267.98 $51,341 - $58,419
218 Added 15.72%
1,605 $401 Million
Q1 2024

May 08, 2024

BUY
$224.58 - $256.19 $311,492 - $355,335
1,387 New
1,387 $346 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Callan Family Office, LLC Portfolio

Follow Callan Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Callan Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callan Family Office, LLC with notifications on news.